The docking results indicated that CZK might interact with Keap1-Nrf2 Kelch domain effectively, demonstrating that CZK could treat ischemic stroke through Nrf2 pathway (Fig. 7). The gene discussed is NFE2L2; the disease is ischemic stroke.